The value of surveillance mammography of the contralateral breast in patients with a history of breast cancer

European Journal of Cancer

Volumn 45, Issue 17, 2009, Pages 3000-3007

  Lu, Wenli ^a,b   Schaapveld, Michael ^c   Jansen, Liesbeth ^a   Bagherzadegan, Emad ^a   Sahinovic, Marko Mirza ^a   Baas, Peter C ^d   Hanssen, Leo M H C ^d   van der Mijle, Hans C J ^d   Brandenburg, Jan D ^a   Wiggers, Theo ^a   De Bock, Geertruida H ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b TIANJIN MEDICAL UNIVERSITY   (China)

^c Integraal Kankercentrum Noord Nederland   (Netherlands)

^d Comprehensive Cancer Centre North Netherlands ^*  (Netherlands)

Author keywords

Breast neoplasm; Contralateral breast cancer (CBC); Surveillance mammography

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER PATIENT; CANCER REGISTRY; CANCER SCREENING; CANCER SURVIVAL; DIAGNOSTIC VALUE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; PATIENT COMPLIANCE; PATIENT IDENTIFICATION; PRIORITY JOURNAL; SENSITIVITY ANALYSIS;

ADULT; AGED; BREAST NEOPLASMS; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; LONG-TERM CARE; MAMMOGRAPHY; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS, SECOND PRIMARY; NETHERLANDS; PATIENT COMPLIANCE; POPULATION SURVEILLANCE; PROGNOSIS;

EID: 70350580941     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2009.08.007     Document Type: Article

References (31)

1. Soerjomataram I., Louwman W.J., Lemmens V.E., et al. Risks of second primary breast and urogenital cancer following female breast cancer in the south of The Netherlands, 1972-2001. Eur J Cancer 41 (2005) 2331-2337
2. Samant R.S., Olivotto I.A., Jackson J.S., and Mates D. Diagnosis of metachronous contralateral breast cancer. Breast J 7 (2001) 405-410
3. Tilanus-Linthorst M.M., Bartels K.C., Alves C., et al. Selection bias influences reported contralateral breast cancer incidence and survival in high risk non-BRCA1/2 patients. Breast Cancer Res Treat 95 (2006) 117-123
4. Gao X., Fisher S.G., and Emami B. Risk of second primary cancer in the contralateral breast in women treated for early-stage breast cancer: a population-based study. Int J Radiat Oncol Biol Phys 56 (2003) 1038-1045
5. Broet P., de la R.A., Scholl S.M., et al. Contralateral breast cancer: annual incidence and risk parameters. J Clin Oncol 13 (1995) 1578-1583
6. Hill-Kayser C.E., Harris E.E., Hwang W.T., and Solin L.J. Twenty-year incidence and patterns of contralateral breast cancer after breast conservation treatment with radiation. Int J Radiat Oncol Biol Phys 66 (2006) 1313-1319
7. Khatcheressian J.L., Wolff A.C., Smith T.J., et al. American Society of Clinical Oncology 2006 update of the breast cancer follow-up and management guidelines in the adjuvant setting. J Clin Oncol 24 (2006) 5091-5097
8. Grunfeld E., Dhesy-Thind S., and Levine M. Clinical practice guidelines for the care and treatment of breast cancer: follow-up after treatment for breast cancer (summary of the 2005 update). CMAJ 172 (2005) 1319-1320
9. ESMO. ESMO Minimum Clinical Recommendations for diagnosis, adjuvant treatment and follow-up of primary breast cancer. Ann Oncol 2001;12:1047-1048.
10. Lu W.L., Jansen L., Post W.J., et al. Impact on survival of early detection of isolated breast recurrences after the primary treatment for breast cancer: a meta-analysis. Breast Cancer Res Treat 114 (2009) 403-412
11. de Bock G.H., Bonnema J., van der H.J., Kievit J., and van d V. Effectiveness of routine visits and routine tests in detecting isolated locoregional recurrences after treatment for early-stage invasive breast cancer: a meta-analysis and systematic review. J Clin Oncol 22 (2004) 4010-4018
12. Montgomery D.A., Krupa K., and Cooke T.G. Follow-up in breast cancer: does routine clinical examination improve outcome? A systematic review of the literature. Br J Cancer 97 (2007) 1632-1641
13. Grunfeld E., Noorani H., McGahan L., et al. Surveillance mammography after treatment of primary breast cancer: a systematic review. Breast 11 (2002) 228-235
14. Field T.S., Doubeni C., Fox M.P., et al. Under utilization of surveillance mammography among older breast cancer survivors. J Gen Intern Med 23 (2008) 158-163
15. Schapira M.M., McAuliffe T.L., and Nattinger A.B. Underutilization of mammography in older breast cancer survivors. Med Care 38 (2000) 281-289
16. Doubeni C.A., Field T.S., Ulcickas Y.M., et al. Patterns and predictors of mammography utilization among breast cancer survivors. Cancer 106 (2006) 2482-2488
17. Ji J., and Hemminki K. Risk for contralateral breast cancers in a population covered by mammography: effects of family history, age at diagnosis and histology. Breast Cancer Res Treat 105 (2007) 229-236
18. Anttila A., Koskela J., and Hakama M. Programme sensitivity and effectiveness of mammography service screening in Helsinki, Finland. J Med Screen 9 (2002) 153-158
19. Carney P.A., Miglioretti D.L., Yankaskas B.C., et al. Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography. Ann Intern Med 138 (2003) 168-175
20. Kolb T.M., Lichy J., and Newhouse J.H. Comparison of the performance of screening mammography, physical examination, and breast US and evaluation of factors that influence them: an analysis of 27, 825 patient evaluations. Radiology 225 (2002) 165-175
21. Kaas R., Hart A.A., Besnard A.P., Peterse J.L., and Rutgers E.J. Impact of mammographic interval on stage and survival after the diagnosis of contralateral breast cancer. Br J Surg 88 (2001) 123-127
22. Montgomery D.A., Krupa K., Jack W.J., et al. Changing pattern of the detection of locoregional relapse in breast cancer: the Edinburgh experience. Br J Cancer 96 (2007) 1802-1807
23. Kollias J., Evans A.J., Wilson A.R., et al. Value of contralateral surveillance mammography for primary breast cancer follow-up. World J Surg 24 (2000) 983-987
24. Mellink W.A., Holland R., Hendriks J.H., et al. The contribution of routine follow-up mammography to an early detection of asynchronous contralateral breast cancer. Cancer 67 (1991) 1844-1848
25. Innos K., and Horn-Ross P.L. Risk of second primary breast cancers among women with ductal carcinoma in situ of the breast. Breast Cancer Res Treat 111 (2008) 531-540
26. Ciatto S., Miccinesi G., and Zappa M. Prognostic impact of the early detection of metachronous contralateral breast cancer. Eur J Cancer 40 (2004) 1496-1501
27. Schaapveld M., Visser O., Louwman W.J., et al. The impact of adjuvant therapy on contralateral breast cancer risk and the prognostic significance of contralateral breast cancer: a population based study in the Netherlands. Breast Cancer Res Treat 110 (2008) 189-197
28. Schootman M., Fuortes L., and Aft R. Prognosis of metachronous contralateral breast cancer according to stage at diagnosis: the importance of early detection. Breast Cancer Res Treat 99 (2006) 91-95
29. Quan G., Pommier S.J., and Pommier R.F. Incidence and outcomes of contralateral breast cancers. Am J Surg 195 (2008) 645-650
30. Humphrey L.L., Helfand M., Chan B.K., and Woolf S.H. Breast cancer screening: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 137 (2002) 347-360
31. Paszat L., Sutradhar R., Grunfeld E., et al. Outcomes of surveillance mammography after treatment of primary breast cancer: a population-based case series. Breast Cancer Res Treat 114 (2009) 169-178